Clinical Trials Browser

Phase 3 × Recruiting × Anemia × Clear all

NCT06499285 2026-05-13

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Phase 3 Recruiting

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes

NCT05407987 2025-04-25

FORGE II

Phase 3 Recruiting

Classical hematology

Anemia, Anemia, Iron-Deficiency